Vasculitis syndromes: Tocilizumab-a new frontier for GCA therapy

Matthew J. Koster; Kenneth J. Warrington

doi:10.1038/nrrheum.2017.150

Vasculitis syndromes: Tocilizumab-a new frontier for GCA therapy

Matthew J. Koster, Kenneth J. Warrington

Rheumatology

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	700-701
Number of pages	2
Journal	Nature Reviews Rheumatology
Volume	13
Issue number	12
DOIs	https://doi.org/10.1038/nrrheum.2017.150
State	Published - Nov 21 2017

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1038/nrrheum.2017.150

Cite this

@article{148e1cb5de154dce8eff1eb064a7f23b,

title = "Vasculitis syndromes: Tocilizumab-a new frontier for GCA therapy",

author = "Koster, {Matthew J.} and Warrington, {Kenneth J.}",

year = "2017",

month = nov,

day = "21",

doi = "10.1038/nrrheum.2017.150",

language = "English (US)",

volume = "13",

pages = "700--701",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Vasculitis syndromes

T2 - Tocilizumab-a new frontier for GCA therapy

AU - Koster, Matthew J.

AU - Warrington, Kenneth J.

PY - 2017/11/21

Y1 - 2017/11/21

UR - http://www.scopus.com/inward/record.url?scp=85034756735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034756735&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2017.150

DO - 10.1038/nrrheum.2017.150

M3 - Short survey

C2 - 28878334

AN - SCOPUS:85034756735

SN - 1759-4790

VL - 13

SP - 700

EP - 701

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 12

ER -

Vasculitis syndromes: Tocilizumab-a new frontier for GCA therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this